{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:57Z","timestamp":1791839877163,"version":"4.3.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":859,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67-year-old man with Pityriasis rubra pilaris might induced by COVID-19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the second dose. He had poor effect and liver function impairment developed after acitretin used, but achieved satisfactory efficacy after replacement to ixekizumab, an interleukin-17A inhibitor.<\/jats:p>","DOI":"10.1002\/ski2.139","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:46:42Z","timestamp":1655448402000},"source":"Crossref","is-referenced-by-count":11,"title":["Ixekizumab Successfully Treated Severe Pityriasis Rubra Pilaris after COVID-19 Vaccination"],"prefix":"10.1093","volume":"3","author":[{"given":"Ya-ting","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-2444","authenticated-orcid":false,"given":"Shang-shang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"3","key":"2025010818121941500_ski2139-bib-0001","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/jamadermatol.2018.5030","article-title":"Pityriasis Rubra Pilaris","volume":"155","author":"Eastham","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2025010818121941500_ski2139-bib-0002","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000524099","article-title":"CoronaVac\/sinovac COVID-19 vaccine-related hypersensitivity reactions and second-dose vaccine administration: Tertiary Allergy Center experience","author":"Gumusburun","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"2025010818121941500_ski2139-bib-0003","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1111\/1462-2920.15549","article-title":"COVID-19: vaccination problems","volume":"23","author":"Br\u00fcssow","year":"2021","journal-title":"Environ Microbiol"},{"issue":"6","key":"2025010818121941500_ski2139-bib-0004","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4103\/0378-6323.168326","article-title":"Pityriasis rubra pilaris occurring after vaccination with diphtheria-pertussis-tetanus and oral poliovirus vaccines","volume":"81","author":"Mohamed","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"2025010818121941500_ski2139-bib-0005","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.annder.2011.01.049","article-title":"Pityriasis rubra pilaris after vaccination","volume":"138","author":"Naciri Bennani","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"12","key":"2025010818121941500_ski2139-bib-0006","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1111\/jdv.17542","article-title":"Pityriasis rubra pilaris after Vaxzevria\u00ae COVID-19 vaccine","volume":"35","author":"Llad\u00f3","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025010818121941500_ski2139-bib-0007","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18055","article-title":"Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: a report of two cases with successful treatment with oral isotretinoin","author":"Criado","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2025010818121941500_ski2139-bib-0008","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/ced.14878","article-title":"Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine","volume":"47","author":"Hunjan","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"2025010818121941500_ski2139-bib-0009","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1684\/ejd.2020.3879","article-title":"Treatment of pityriasis rubra pilaris: a case series of 28 patients","volume":"30","author":"Kromer","year":"2020","journal-title":"Eur J Dermatol"},{"issue":"1","key":"2025010818121941500_ski2139-bib-0010","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1111\/j.1468-3083.2012.04456.x","article-title":"A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists","volume":"27","author":"Petrof","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"2025010818121941500_ski2139-bib-0011","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaad.2018.02.063","article-title":"Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: a review","volume":"79","author":"Maloney","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2025010818121941500_ski2139-bib-0012","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","volume":"153","author":"Feldmeyer","year":"2017","journal-title":"Interleukin 23-helper T cell 17 Axis as a treatment target for pityriasis rubra pilaris"},{"issue":"4","key":"2025010818121941500_ski2139-bib-0013","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13644","article-title":"Successful treatment of resistant pityriasis rubra pilaris with ixekizumab","volume":"33","author":"Penalba-Torres","year":"2020","journal-title":"Dermatol Ther"},{"issue":"6","key":"2025010818121941500_ski2139-bib-0014","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-Arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2025010818121941500_ski2139-bib-0015","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/ajd.13614","article-title":"A case of treatment-resistant pityriasis rubra pilaris responsive to secukinumab","volume":"62","author":"Simpson","year":"2021","journal-title":"Australas J Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ski2.139","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ski2.139","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/3\/1\/ski2.139\/59935108\/skinhd_3_1_e139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/3\/1\/ski2.139\/59935108\/skinhd_3_1_e139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:12:26Z","timestamp":1736359946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.139\/7755612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.139","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,6,16]]},"article-number":"ski2.139"}}